Gain Therapeutics Inc (GANX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -664.545 | -69.7 | -57.05 | -55.77 | -103.536 |
Return on Equity (%) | 974.667 | -124.374 | -67.577 | -65.518 | -140.562 |
Return on Invested Capital (%) | 914.009 | -108.998 | -65.383 | -67.762 | -145.776 |
Operating Margin (%) | -5280.488 | -12317.241 | -8397.576 | -12498.571 | -40341.818 |
Net Profit Margin (%) | -5348.78 | -12334.483 | -8400 | -12565 | -40198.182 |
Book Value Per Share | -0.2 | 1.542 | 2.913 | 1.571 | 0.959 |
Earnings Per Share | -0.975 | -0.889 | -1.166 | -1.48 | -1.713 |
Cash Per Share | 0.135 | 1.863 | 3.104 | 0.613 | 0.914 |
Working Capital Per Share | -0.2 | 1.708 | 2.96 | 1.428 | 0.994 |
Operating Profit Per Share | 0.018 | 0.007 | 0.016 | 0.012 | 0.004 |
EBIT Per Share | -0.972 | -0.888 | -1.166 | -1.473 | -1.719 |
EBITDA Per Share | -0.972 | -0.888 | -1.166 | -1.473 | -1.719 |
Free Cash Flow Per Share | -0.97 | -0.886 | -1.16 | -1.476 | -1.718 |
Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,25M | 4,02M | 11,88M | 11,88M | N/A |
Fin d'année 31 Décembre 2023 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
Actions en circulation | 11,88M | 11,88M | N/A | 12,63M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -9309.091 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -9340 | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 42,44M |
Ratio cours/bénéfice | -1,92 |
Ratio prix/ventes | 761,9 |
Ratio prix/liquidités | 3,6 |
Ratio prix/valeur comptable | 3,37 |
Rendement de dividende | - |
Actions en circulation | 26,53M |
Volume moyen (1 semaine) | 140,14k |
Volume moyen (1 mois) | 202,31k |
Variation sur 52 semaines | -39,85% |
Plus haut sur 52 semaines | 5,33 |
Plus bas sur 52 semaines | 0,89 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales